NAD+ IV vs NAD+ Injection

What you are comparing

Clinics sell NAD+ IV—often hundreds of milligrams in saline over one to several hours—and NAD+ injections, usually intramuscular or subcutaneous over minutes. Both put nicotinamide adenine dinucleotide, or a related clinic protocol, into you without a pill. Head-to-head outcome data in healthy adults are thin. Flushing, chest tightness, and nausea are more famous on the slow IV because the dose and rate are higher. Shots are faster and usually cheaper. They are not a proven same NAD, less time equivalent.

NAD+ is a coenzyme involved in redox reactions. ODS niacin fact sheets describe how the body makes NAD from vitamin B3 vitamers. That biochemistry is not a license to call a lounge drip anti-aging medicine. NCCIH reminds patients that dietary supplements taken by mouth are not FDA-approved disease treatments. Parenteral NAD+ sold for energy or longevity is typically compounded and investigational.

This comparison is for adults offered a choice of drip versus shot on a wellness menu. It is not a review of prescription niacin for lipids, and it is not a hospital protocol for a rare metabolic disease. If a clinic promises reversed aging, cellular energy optimization, or a cured addiction from one bag, you are hearing marketing.

How they differ

Time and tolerability differ first. A PMC retrospective comparison of commercial 500 mg NAD+ IV versus nicotinamide riboside IV found more moderate-to-severe gastrointestinal symptoms, increased heart rate, and chest pressure with NAD+ IV, and longer average infusion times. Shots skip hours in a chair but still can sting, bruise, or irritate a vein if someone tries a quick push into a poorly sited catheter.

Dose and pharmacokinetics differ next. An IV can deliver a larger milligram load into blood. Whether that raises tissue NAD+ in a useful way, or simply generates metabolites you excrete, is not settled for wellness dosing. A shot deposits a smaller amount in muscle or skin. Clinics sometimes call that a boost. There is no strong trial showing matching anti-aging outcomes.

Risk differs in kind more than in slogan. IV adds infiltration, phlebitis, and uncommon bloodstream infection; PMC catheter reviews treat those as reasons to have an indication. Injections add local pain, rare abscess, and sciatic injury if landmarks are wrong. Both require CDC-standard sterile technique. Compounded product quality is a shared uncertainty. FDA says compounded drugs are not FDA-approved.

• NAD+ IV: longer session, more flushing and rate problems, vein plus fluid load.
• NAD+ shot: minutes, local injection risk, not a proven dose-equivalent.
• Oral B3 / NR supplements: different objects; still not proven anti-aging drugs.
• Either parenteral route: investigational wellness use, not standard geriatric care.

Who each option is for

Neither option is a standard treatment for aging, ordinary fatigue, or athletic performance. A medically stable adult who understands that, accepts flushing and vein risk, and has been screened for heart disease may still request an investigational drip. That is preference, not an indication. People with unstable angina, decompensated heart failure, or a tendency to vasovagal collapse are a poor fit for a long, symptomatic infusion.

A shot may fit someone who refuses hours of chest tightness but still wants a clinic product. It is a poor choice if you expect the same milligram effect as a multi-hour IV, or if no one will explain the dose. It is also a poor choice if the injector cannot manage anaphylaxis.

Oral counseling about niacin, diet, sleep, and alcohol is the least invasive path and should be offered first. Pregnancy, breastfeeding, and active substance withdrawal need medical settings, not a NAD+ membership. Do not use a drip to delay alcohol-withdrawal care.

Risks of choosing the wrong one

Choosing a fast IV push to save time is how flushing becomes chest pressure and a stopped infusion. Choosing a shot because it is cheaper, then stacking weekly injections without a question you can measure, wastes money and normalizes unnecessary needles. Choosing either as anti-aging care can delay indicated cardiovascular prevention, cancer screening, or treatment of depression.

Vein injury from repeated NAD+ IVs is a practical harm: sclerosis, infiltration, and harder access later when you need a real hospital IV. Infection from poor technique is the avoidable disaster CDC injection-safety pages exist to prevent. Compounded lot errors are quieter and still serious.

Believing a biomarker printout of NAD+ metabolites proves youth is a cognitive risk. ODS discusses niacin status, not a longevity score. A number that rose after a bag is target engagement at best, not a healthspan trial.

How to decide

Decide whether you have a medical question a licensed clinician owns. If the question is aging or energy and labs are otherwise unremarkable, prefer food, sleep, activity, and indicated primary care. If you still want NAD+, treat it as investigational: written dose, route, compounding source, and a plan to stop for chest pain, wheeze, or a swelling arm.

If you choose IV, insist on a slow rate, site checks, and vital-sign monitoring. If you choose a shot, insist on landmarks, a new needle, and the same ingredient transparency. Compare total cost for a series, not a first-visit discount. Do not buy a package that assumes you will feel younger.

Set a stop rule after one or two sessions if the only result was flushing and a credit-card charge. Send records to your primary clinician. Keep veins and muscle for medicines with labeled indications. Wellness NAD+ uses remain investigational. Flushing and vein issues are expected talking points, not badges of efficacy. Neither route is proven anti-aging therapy.